Test Price
2,800 AED✅ Home Collection Available
CLCN4 Gene Raynaud‑Claes Syndrome Genetic Test in UAE
Executive Summary & Core Metrics
🔬 Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
🚑 Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
📞 Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation with genetic counselling referral.
💳 Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Corporate Oversight: Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA ID: 9294403) supervises all clinical reporting for this assay.
Test Overview & Methodology
The CLCN4 gene test utilizes Next Generation Sequencing (NGS) to deliver superior diagnostic accuracy for Raynaud‑Claes syndrome compared to conventional Sanger sequencing. Full gene coverage including flanking intronic regions ensures detection of pathogenic variants that alternative methods may miss.
| Parameter | Our Test (NGS) | Sanger Single‑Gene Test |
|---|---|---|
| Precision / Sensitivity | 99.9% analytical sensitivity | ~95% for coding regions only |
| Methodology | NGS (Full gene + flanking intronic regions) | Sanger sequencing (limited coverage) |
| Turnaround Time | 3 – 4 Weeks | 6 – 8 Weeks |
| Clinical Interpretation | Includes telephonic guidance + genetic counselling referral | Usually report only |
Physician Insight & Safety Protocols
"As a Consultant Medical Geneticist, I recognize the profound uncertainty families face when investigating a possible diagnosis of Raynaud‑Claes syndrome. This NGS-based test offers comprehensive genomic coverage that is essential for accurate diagnosis and informed clinical management. However, genetic results must always be interpreted within the full clinical context. I strongly recommend post-test genetic counselling to fully understand the implications for the patient and family members."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Medication Advisory
Do not discontinue, alter, or adjust any prescribed medication without explicit consultation with your treating physician. Genetic test results may inform future therapeutic decisions but should never prompt immediate medication changes without clinical correlation.
Exclusion Criteria & Clinical Red Flags
- Exclusion: Active febrile infection, recent blood transfusion (within 8 weeks), or non-consenting minor (guardian consent mandated per Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Exclusion: Severe needle phobia or lack of venous access; alternative dried blood spot card via finger prick may be considered – discuss during booking.
- Emergency Red Flags: New-onset seizures, sudden loss of developmental milestones, or altered consciousness require immediate hospital evaluation, not elective genetic testing.
Patient FAQ & Clinical Guidance
1. What is the exact cost and turnaround time for the CLCN4 gene test in Dubai / UAE?
The CLCN4 NGS test costs AED 2,800 and results are ready in 3 to 4 weeks. This price includes the full gene sequencing, bioinformatics analysis, and a telephonic clinical interpretation session with our genetic counsellor. Home collection may incur an additional logistics fee which is communicated during booking.
2. What sample is required and how is the home collection arranged?
A single peripheral whole blood sample (or DNA extract / FTA card) is needed; we deploy a certified mobile phlebotomist. After verifying insurance or payment, a trained nurse visits your home between 8 AM and 11 PM, follows cold-chain protocols, and transports the sample to our ISO‑accredited laboratory.
3. Is a doctor referral required and will my insurance cover this test?
A referral from a neurologist or medical geneticist is recommended but not mandatory; direct billing is verified. Many UAE insurers cover genetic testing for neurodevelopmental disorders when medically justified. Send your Emirates ID and insurance card via WhatsApp to +971 54 548 8731, and our team will confirm eligibility within one working day.
UAE Regulatory & Data Privacy Adherence
ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) · Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) · Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields · Federal Decree-Law No. 4 of 2016 on Medical Liability
All patient data is encrypted in transit and at rest. Access is restricted to authorized clinical personnel only. Consent documentation and data processing records are maintained in compliance with PDPL Article 12 requirements.
Clinical & Logistical Metadata
| Test Name | CLCN4 Gene Raynaud‑Claes Syndrome Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 – 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood, DNA Extract, or FTA Card |
| Methodology Used | Next Generation Sequencing (NGS) – Full Gene Coverage Including Flanking Intronic Regions |
| ICD-10-CM Code | Q87.8 |
| LOINC Code | 21636-6 |
| DHA Facility License & Laboratory Address | DHA Facility License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians